Jantoven and Bradycardia - a phase IV clinical study of FDA data

Summary:

Bradycardia is reported as a side effect among people who take Jantoven (warfarin sodium), especially for people who are female, 60+ old, also take Digoxin, and have High blood pressure.

The phase IV clinical study analyzes which people have Bradycardia when taking Jantoven. It is created by eHealthMe based on reports of 1,546 people who have side effects when taking Jantoven from the FDA, and is updated regularly.

What is Jantoven?

Jantoven has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 1,608 Jantoven users. Check the latest studies of Jantoven.

What is Bradycardia?

Bradycardia (abnormally slow heart action) is found to be associated with 1,911 drugs and 3,118 conditions by eHealthMe. Check the latest studies of Bradycardia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

1,546 people reported to have side effects when taking Jantoven.
Among them, 13 people (0.84%) have Bradycardia.

Among these 13 people:

What is the gender of people who have Bradycardia when taking Jantoven? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Bradycardia when taking Jantoven? *

What are other drugs people take besides Jantoven? *

What are other side effects people have besides Bradycardia? *

Pain: 7 people, 53.85%
Anaemia (lack of blood): 6 people, 46.15%
Stress And Anxiety: 6 people, 46.15%
Cardiac Failure Congestive: 5 people, 38.46%
Dizziness: 5 people, 38.46%
Emotional Distress: 5 people, 38.46%
Fall: 5 people, 38.46%
Weakness: 5 people, 38.46%
Injury: 5 people, 38.46%
Atrioventricular Block Complete (heart block complete): 5 people, 38.46%

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 23.08%
High Blood Pressure: 3 people, 23.08%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 15.38%
Rickets (softening of bones): 1 person, 7.69%
Oedema (fluid collection in tissue): 1 person, 7.69%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 7.69%
High Blood Cholesterol: 1 person, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%
Depression: 1 person, 7.69%
Cardiac Failure Congestive: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Jantoven and have Bradycardia?

- Check whether Bradycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Jantoven:

Jantoven (1,608 reports)

Bradycardia treatments and more:

Bradycardia (61,180 reports)

Browse all side effects of Jantoven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bradycardia:

Bradycardia (1,911 drugs)

Browse all the conditions that are associated with Bradycardia:

Bradycardia (3,118 conditions)

Related publications that referenced our studies

Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD, "Bradycardia seen in children with Crimean-Congo hemorrhagic fever", Vector-Borne and Zoonotic Diseases, 2013 Nov .
Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD, "Bradycardia seen in children with Crimean-Congo hemorrhagic fever", Vector-Borne and Zoonotic Diseases, 2013 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on warfarin sodium (the active ingredients of Jantoven) and Jantoven (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.